#hemostasis diagnostics

Hemostasis diagnostics help identify the hemostatic defects that cause excessive bleeding. Hemostasis is a process of slowing and stopping the blood flow to initiate wound healing after a vascular injury and is the key procedure acting in the first line of action adopted by the body. During the process, blood changes its form from fluid state to gelatinous state. Hemostasis is maintained in the body via three mechanisms namely vasoconstriction, platelet plug formation and blood coagulation.

The diagnosis helps predict the cause of excessive bleeding during the surgery, identifies hemostatic defects in patients with a history of excessive bleeding. Based on the research articles published by medical experts, the appropriate therapy to treat hemorrhage can be administered of fresh frozen plasma for coagulation defects, Von Willebrand factor concentrates for platelet function defects or antifibrinolytic agents for systemic fibrinolysis.

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/434

The growing technological advances in molecular diagnostics, inexpensive and biodegradable diagnostic products, chromogenic substrates, monoclonal antibodies, immunoassays, laboratory automation is estimated radically change the Hemostasis diagnostics market over the following five years.

The global hemostasis diagnostics market is segmented on the basis of product type, technology, end user and geography.

U.S. Beckman Coulter holds over half the U.S. market for Hematology devices

Key players operating in the market are HORIBA, Ltd., Abbott Laboratories, Siemens AG, and Bio-Rad Laboratories, Inc. The high and low end analyzers provided by U.S. Beckman Coulter meet the needs of all hematology testing environment. Other vendors who have adopted ideal product models, business expansion and market appeal strategies are Becton, Dickinson & Company, Grifols S.A, Alere, Inc., F. Hoffmann-La Roche AG, Beckman Coulter Inc. Sekisui, Helena Labor, Chrono-Log, and Axis-Shield. Click To Read More On Hemostasis Diagnostics Market